User profiles for Peter D. Katsikis
Peter KatsikisProfessor, Department of Immunology, Erasmus University Medical Center Verified email at erasmusmc.nl Cited by 12603 |
Convalescent plasma for COVID-19. A randomized clinical trial
…, P Boekhorst, FH Swaneveld, PD Katsikis… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
[PDF][PDF] The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes
…, L Boon, A Moyaart, YM Mueller, PD Katsikis… - Cancer cell, 2020 - cell.com
PD-1/PD-L1-checkpoint blockade therapy is generally thought to relieve tumor cell-mediated
suppression in the tumor microenvironment but PD-L1 is also expressed on non-tumor …
suppression in the tumor microenvironment but PD-L1 is also expressed on non-tumor …
Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
PD Katsikis, ES Wunderlich, CA Smith… - The Journal of …, 1995 - rupress.org
Apoptosis (programmed cell death) of T lymphocytes has been proposed as a mechanism
which plays an important role in the pathogenesis of human immunodeficiency virus (HIV) …
which plays an important role in the pathogenesis of human immunodeficiency virus (HIV) …
[HTML][HTML] The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?
PD Katsikis, YM Mueller, F Villinger - PLoS pathogens, 2011 - journals.plos.org
Cytokines play a central role in the pathogenesis of many diseases, including HIV infection.
However, the role of the cytokine network in early HIV infection is only now starting to be …
However, the role of the cytokine network in early HIV infection is only now starting to be …
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
M Walmsley, PD Katsikis, E Abney… - … : Official Journal of …, 1996 - Wiley Online Library
Objective. Interleukin‐10 (IL‐10) is a potent inhibitor of the proinflammatory cytokines, including
tumor necrosis factor α and IL‐1, which are considered important in the pathogenesis of …
tumor necrosis factor α and IL‐1, which are considered important in the pathogenesis of …
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
PD Katsikis, CQ Chu, FM Brennan, RN Maini… - The Journal of …, 1994 - rupress.org
The presence and the role of interleukin 10 (IL-10), a potent cytokine synthesis inhibitory
factor and antiinflammatory cytokine, were investigated in rheumatoid arthritis (RA). The …
factor and antiinflammatory cytokine, were investigated in rheumatoid arthritis (RA). The …
The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling
We found upregulation of expression of the microRNA miR-155 in primary effector and effector
memory CD8 + T cells, but low miR-155 expression in naive and central memory cells. …
memory CD8 + T cells, but low miR-155 expression in naive and central memory cells. …
In vivo detection and imaging of phosphatidylserine expression during programmed cell death
FG Blankenberg, PD Katsikis, JF Tait… - Proceedings of the …, 1998 - National Acad Sciences
One of the earliest events in programmed cell death is the externalization of phosphatidylserine,
a membrane phospholipid normally restricted to the inner leaflet of the lipid bilayer. …
a membrane phospholipid normally restricted to the inner leaflet of the lipid bilayer. …
[HTML][HTML] In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses
Given the key role CD8 + T cells play in controlling viral infection, strategies to enhance
these responses may have important clinical applications. We found that in vivo CD137 …
these responses may have important clinical applications. We found that in vivo CD137 …
Challenges in developing personalized neoantigen cancer vaccines
PD Katsikis, KJ Ishii, C Schliehe - Nature Reviews Immunology, 2024 - nature.com
The recent success of cancer immunotherapies has highlighted the benefit of harnessing the
immune system for cancer treatment. Vaccines have a long history of promoting immunity to …
immune system for cancer treatment. Vaccines have a long history of promoting immunity to …